These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 8173136)

  • 1. Antistreptokinase antibodies following a dose of streptokinase.
    Chesser SL; Mauro VF
    Ann Pharmacother; 1994 Feb; 28(2):204-6. PubMed ID: 8173136
    [No Abstract]   [Full Text] [Related]  

  • 2. Streptokinase immunogenicity in thrombolytic therapy for acute myocardial infarction.
    Rosenschein U; Lenz R; Radnay J; Ben Tovim T; Rozenszajn LA
    Isr J Med Sci; 1991 Oct; 27(10):541-5. PubMed ID: 1955306
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of intrapleural streptokinase administration on antistreptokinase antibody level in patients with loculated pleural effusions.
    Laisaar T; Pullerits T
    Chest; 2003 Feb; 123(2):432-5. PubMed ID: 12576362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Should streptokinase be readministered? Insights from recent studies of antistreptokinase antibodies.
    Cross DB
    Med J Aust; 1994 Jul; 161(2):100-1. PubMed ID: 8028530
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparative study of the reactivity of natural and mutated streptokinase with total antistreptokinase antibodies in human sera.
    Bandehpour M; Sharifnia Z; Mohajeri N; Taherkhani M; Koochaki A; Yarian F; Seyyed N; Shirvani R; Pakzad P; Saadat H; Kazemi B
    Blood Coagul Fibrinolysis; 2012 Dec; 23(8):734-8. PubMed ID: 23080363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypersensitivity reactions to streptokinase.
    Singh J; Hart G
    Eur Heart J; 1994 Aug; 15(8):1153-4. PubMed ID: 7988614
    [No Abstract]   [Full Text] [Related]  

  • 7. Antistreptokinase antibodies before and after streptokinase therapy in patients with acute myocardial infarction from areas endemic for streptococcal infection and influence on reperfusion rates.
    Shaila G; Chandrashekhar YS; Kumar N; Ganguly NK; Anand IS
    Am J Cardiol; 1994 Jul; 74(2):187-9. PubMed ID: 8023789
    [No Abstract]   [Full Text] [Related]  

  • 8. Monitoring of streptokinase resistance titre in acute myocardial infarction patients up to 30 months after giving streptokinase or anistreplase and related studies to measure specific antistreptokinase IgG.
    Fears R; Ferres H; Glasgow E; Standring R; Hogg KJ; Gemmill JD; Burns JM; Rae AP; Dunn FG; Hillis WS
    Br Heart J; 1992 Aug; 68(2):167-70. PubMed ID: 1389731
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of pretreatment antistreptokinase antibody and streptococcal infection on the efficacy and dosage of streptokinase in acute myocardial infarction.
    Abuosa AM; Akhras F; Sorour K; El-Said G; El-Tobgy S; Kinsara AJ
    Saudi Med J; 2005 Jun; 26(6):934-6. PubMed ID: 15983677
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Thrombolysis in acute myocardial infarct].
    Görge G; Erbel R
    Dtsch Med Wochenschr; 1994 May; 119(19):717. PubMed ID: 8187628
    [No Abstract]   [Full Text] [Related]  

  • 11. Antistreptokinase titres after intravenous streptokinase.
    Lancet; 1990 Mar; 335(8688):534. PubMed ID: 1968541
    [No Abstract]   [Full Text] [Related]  

  • 12. [Anti-streptokinase antibodies].
    Helft G; Lecompte T; Le Feuvre C; Metzger JP; Vacheron A; Samama MM
    Arch Mal Coeur Vaiss; 1997 Jul; 90(7):975-80. PubMed ID: 9339259
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Anaphylactic reaction in streptokinase therapy].
    Hohage H; Schulte B; Pfeiff B; Pullmann H
    Wien Klin Wochenschr; 1993; 105(6):176-8. PubMed ID: 8475630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-streptokinase titers and response to streptokinase treatment in Pakistani patients.
    Kazmi KA; Perwaiz Iqbal M; Rahbar A; Mehboobali N
    Int J Cardiol; 2002 Mar; 82(3):247-51. PubMed ID: 11911912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Calculated initial dose of streptokinase in relation to age, and history of throat infections].
    Ott P; Raunkjaer B; Glazer S; Knudsen JB
    Ugeskr Laeger; 1988 Jan; 150(4):215-7. PubMed ID: 3376326
    [No Abstract]   [Full Text] [Related]  

  • 16. A mutant streptokinase lacking the C-terminal 42 amino acids is less reactive with preexisting antibodies in patient sera.
    Torréns I; Ojalvo AG; Seralena A; Pupo E; Lugo V; Páez R
    Biochem Biophys Res Commun; 1999 Dec; 266(1):230-6. PubMed ID: 10581194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antistreptokinase titres after intravenous streptokinase.
    Jalihal S; Morris GK
    Lancet; 1990 Jan; 335(8683):184-5. PubMed ID: 1967665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Raised levels of antistreptokinase antibody and neutralization titres from 4 days to 54 months after administration of streptokinase or anistreplase.
    Lee HS; Cross S; Davidson R; Reid T; Jennings K
    Eur Heart J; 1993 Jan; 14(1):84-9. PubMed ID: 8432298
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neutralising antibodies after streptokinase treatment for myocardial infarction: a persisting puzzle.
    McGrath K; Hogan C; Hunt D; O'Malley C; Green N; Dauer R; Dalli A
    Br Heart J; 1995 Aug; 74(2):122-3. PubMed ID: 7546988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Are streptokinase antibodies clinically important?
    Lynch M; Littler WA; Pentecost BL; Stockley RA
    Br Heart J; 1994 Mar; 71(3):303-4. PubMed ID: 8142204
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.